Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT00006493
Eligibility Criteria:
Inclusion Criteria:
* HIV-positive with CD4 count \> 500 and undetectable viral load
* Treated with protease inhibitors for more than three months
* Serum triglycerides \> 400mg/dl
* Clinical diagnosis of HIV-associated lipodystrophy
* No history of type II diabetes
* Fasting blood sugar \< 126 mg/dl
* No history of liver disease
* Negative Hepatitis B antigen and Hepatitis C antibody
* Not on the following medications: warfarin, digoxin, nifedipine, erythromycin, cyclosporine or HMG coA-reductase inhibitors
* Hemoglobin \> 11g/dl
* Women of childbearing age must consent to barrier contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00006493
Study Brief:
Protocol Section:
NCT00006493